NCT02924480View on ClinicalTrials.gov

Intravenous Lidocaine for Cystectomy Procedures

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 12, 2016

Primary Completion Date

June 17, 2020

Study Completion Date

June 17, 2020

Conditions
Invasive Bladder Cancer
Interventions
PROCEDURE

Cystectomy

DRUG

Lidocaine

Patients will receive lidocaine infusion during surgery

DRUG

Saline

Patients will receive saline infusion during surgery

Trial Locations (1)

25301

Urology center of charleston, Charleston

All Listed Sponsors
lead

CAMC Health System

OTHER

NCT02924480 - Intravenous Lidocaine for Cystectomy Procedures | Biotech Hunter | Biotech Hunter